MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 95 filers reported holding MAGENTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 244 | -98.4% | 0.00% | – |
| Q1 2022 | $43,000 | -34.8% | 14,914 | 0.0% | 0.00% | – |
| Q4 2021 | $66,000 | -39.4% | 14,914 | -0.4% | 0.00% | – |
| Q3 2021 | $109,000 | -56.7% | 14,971 | -41.8% | 0.00% | – |
| Q2 2021 | $252,000 | +39.2% | 25,736 | +68.5% | 0.00% | – |
| Q1 2021 | $181,000 | +98.9% | 15,270 | +32.0% | 0.00% | – |
| Q4 2020 | $91,000 | +167.6% | 11,570 | +128.2% | 0.00% | – |
| Q3 2020 | $34,000 | -10.5% | 5,070 | 0.0% | 0.00% | – |
| Q2 2020 | $38,000 | -64.8% | 5,070 | -70.5% | 0.00% | – |
| Q1 2020 | $108,000 | -58.5% | 17,170 | 0.0% | 0.00% | – |
| Q4 2019 | $260,000 | +18.7% | 17,170 | -19.4% | 0.00% | – |
| Q3 2019 | $219,000 | -30.3% | 21,300 | 0.0% | 0.00% | – |
| Q2 2019 | $314,000 | +307.8% | 21,300 | +353.2% | 0.00% | – |
| Q1 2019 | $77,000 | +185.2% | 4,700 | 0.0% | 0.00% | – |
| Q4 2018 | $27,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 8,008,204 | $50,292,000 | 45.98% |
| Casdin Capital, LLC | 2,971,034 | $18,658,000 | 1.98% |
| Alphabet Inc. | 3,339,138 | $20,970,000 | 1.38% |
| Opaleye Management Inc. | 434,712 | $2,730,000 | 0.72% |
| Bleichroeder LP | 251,875 | $1,582,000 | 0.41% |
| Eventide Asset Management | 1,789,646 | $11,239,000 | 0.36% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,089,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 4,059,789 | $25,495,000 | 0.31% |
| Leap Investments LP | 12,600 | $79,000 | 0.12% |
| Aries Wealth Management | 12,000 | $77,000 | 0.06% |